Brief: Lee's Pharmaceutical Posts FY Profit Attributable HK$129.3 Mln Vs HK$125.6 Mln
30/03/2021 11:30
March 30 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* RECOMMENDS PAYMENT OF FINAL DIVIDEND OF HK3.1 CENTS PER
ORDINARY
SHARE
* FY REVENUE HK$1.22 BILLION VERSUS HK$1.22 BILLION
* FY PROFIT ATTRIBUTABLE HK$129.3 MLN VS HK$125.6 MLN
Source text for Eikon: ID:nHKS2FZ49T
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals